FAQ/Help |
Calendar |
Search |
Today's Posts |
|
02-21-2015, 04:03 AM | #1 | |||
|
||||
Grand Magnate
|
Thanks for that link zanpar321.
It looks like a very encouraging study to me though 12 subjects is not a big number. The Journal of Clinical Investigation is a top-quality (impact factor ~14) journal so any manuscript which survives peer-review to get published there is worth careful attention. There is a free-access link to the paper here: http://www.jci.org/articles/view/79635 |
|||
Reply With Quote |
Reply |
|
|
Similar Threads | ||||
Thread | Forum | |||
1st patientPhase I clinical trial of the regenerative cell therapy NTCELL - pig cells | Parkinson's Disease | |||
Adult Stem Cell Research Reverses Effects of Parkinson's Disease in Human Trial | Parkinson's Disease | |||
Growth Factor promotes new neuron growth in mouse model and crosses BBB | Parkinson's Disease | |||
Growth factor stimulates rapid extension of key motor neurons in brain | ALS |